Search for new antihistaminic compounds by molecular connectivity

Quantitative Structure-Activity Relationships

Volumn 18, Issue 1, 1999, Pages 35-42

  Casaban Ros E ^b   Anton Fos G M ^a   Galvez J ^b   Duart, M J ^a   Garcia Domenech R ^b  

^a CEU San Pablo   (Spain)

^b NONE

Author keywords

Antihistaminic drugs; Linear discriminant analysis; Molecular connectivity; Quantitative structure activity relationships; Topological descriptors

Indexed keywords

TOPOLOGY;

ACTIVE COMPOUNDS; ANTIHISTAMINIC DRUG; CONCENTRATION EFFECTS; LINEAR DISCRIMINANT ANALYZE; MOLECULAR CONNECTIVITY; PHARMACOLOGICAL PROPERTIES; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP; SEDATIVE EFFECT; TERFENADINE; TOPOLOGICAL DESCRIPTORS;

DISCRIMINANT ANALYSIS;

ANTIHISTAMINIC AGENT; NEW DRUG;

ARTICLE; DISCRIMINANT ANALYSIS; DRUG ACTIVITY; DRUG BLOOD LEVEL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0033027963     PISSN: 09318771     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3838(199901)18:1<35::AID-QSAR35>3.0.CO;2-Q     Document Type: Article

References (24)

1. Lahana, R., Virtual combinatorial chemistry, Scientific American Edición espanola, 1997, 254, 25.
2. Kier, L.B., Hall, L.H., Molecular connectivity in structure-activity analysis, Research Studies Press, Letchworth, England (1986).
3. Munoz, C., Julian-Ortiz, J.V. de, Gimeno, C. Catalán V., Gálvez, L., Deteccion y ensayo de nuevos compuestos activos frente a virus herpes simplex I., Rev. Esp. Quimioter. 7, 279-280 (1994).
4. Gálvez, J., García R., Julian-Ortiz, J. V. de, Soler, R., Topological approach to drug design, J. Chem. Inf Comput. Sci. 35 (2), 272-284 (1995).
5. Gálvez. L, Gomez-Lechón, M.J., García-Doménech, R., Castell, J.V., New cytostatic agents obtainer by molecular topology, Bioorg. & Med. Chem. Lett., 6 (19), 2301-2306 (1996).
6. Antón-Fos, G.M., García-Doménech, R., Perez-Gimenez, F., Peris-Ribera, J.E., García-March, F.J., Salabert-Salvador, M.T., Pharmacological studies of the two new hypoglycaemic compounds 4-(4-methyl-5-oxo-2-pyrazolin-1-yl) benzoic acid and 1-(mesytilen-2-sulfonyl)I-H-1,2,4-triazole, Arzneim-Forsch/Drug Res. 44 (2), 821-826 (1994).
7. García-Doménech, R., Gregorio Alapont, c. de, Julián-Ortiz. J.V. de, Gálvez, J., Popa. L., Molecular connectivity to find beta-blockers with low toxicity, Bioorg. & Med. Chem. Lett. 7 (5), 567-572 (1997).
8. Gálvez, L, Garcia, R., Julian-Ortiz, J.V. de, Soler, R., Topological approach to analgesia, J. Chem. Inf. Comput. Sci. 34 (5), 1198-1203 (1994).
9. García-Doménech, R., García-March, F.J., Soler, R., Gálvez, J., Antón-Fos, G.M., Julián-Ortiz, J.V. de, New analgesic designed by molecular topology, Quant. Struct.-Act. Relat. 15, 201-207 (1996).
10. Rios-Santamarina, I., Galvez, J, García-Doménech, R., Corijo, J., Santamaria, P., Morcillo, E., New bronchodilators selected by molecular topology, Bioorg. & Med. Chem. Lett., 8, 477-487 (1998).
11. Gozalbes, R., Galvez, J. Moreno, A., García-Doménech, R., New antimalarials found by molecular connectivity, J. Pharm. Pharmacol., in press (1998).
12. Estrada, E., Pena, P., García-Doménech, R., Designing sedative hypnotic compounds from a novel substructural graph-theoretical approach, J. Comput. Aid. Mol. Des., in press (1998).
13. Randíc, M., On characterization of molecular branching, J. Am. Chem. Soc. 97, 6609-6615 (1975).
14. Kier, L.B., Hall, L.H., Molecular connectivity in chemistry and drug research, Academic Press, London, pp. 46-79 (1976).
15. Dixon, W.J., Manual BMD 'Biomedical computer programs', University of California Press, Los Angeles, 1982
16. Galvez, J., García-Doménech, R., Gregorio Alapont, C. de, Julián-Ortiz, J.V. de, Salabert-Salvador, M.T., Soler, R., Advances in molecular similarity, Vol 1, JAI Press Inc., pp. 267-280, (1996)
17. Galvez, L, García-Doménech, R., Gregorio Alapont, C. de, Julián-Ortiz, J.V. de, Popa, L., Pharmacological distribution diagrams: A tool for the novo drug desing, J. Mol. Graph., 14, 272-276 (1996).
18. Gaddum, J.H., Pharmacology, 5th De. Oxford, University Press, London (1959).
19. Vos, C. de, Maleaux, M.R., Baltes, E., Gobert, J., Inhibition of histamine an allergen skin wheal by cetirizine in four animal species, Annals of Allergy, 59, 278-282 (1987).
20. Kier, L.B. and Hall, L.H., A differential molecular connectivity index, Quant. Struct.-Act. Relat., 10, 134-140 (1989).
21. Kier, L.B. and Hall, L.H., Differential molecular connectivity in database fragment searching, Pharm. Res., 6, 497-500 (1989).
22. Woodward, J.K., Pharmacology and toxicology of nonclassical antihistamines, Cutis. 42, 5-9 (1988).
23. Estelle, E, Pharmacokinetics optimisation of histamine H1 receptor antagonist therapy, Clinpharmacokinetic, 21 (5), 372-393 (1991).
24. Hey, J.A., Antihistamine activity, central nervous system and cardiovascular profiles of histamine H1 antagonist: comparative studies with loratadine, terfenadine and sedating antihistamines in guinea pigs, Clin. Exp. Allergy, 25 (10), 974-984 (1995).